Statistics for Basilea Pharmaceutica AG (id:13109 BSLN)
Valuation metrics
Market cap
499.39M
Enterprise value
548.87M
Trailing P/E (ttm)
53.08
Forward P/E
11.51
PEG ratio
11.51
Price/Sales (ttm)
3.35
Price/Book (mrq)
29.75
Enterprise Value/Revenue
3.68
Enterprise Value/EBITDA
-98.07
Overview
Shares outstanding
12.12M
Float
12.11M
Shares short
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
25.64K
Average volume (90 days)
Price summary
52-Week low
32.00
52-Week high
47.95
52-Week change
13.38%
Beta
3.00
50-Day moving average
42.96
200-Day moving average
41.63
Dividends and splits
Forward annual dividend rate
20.00
Forward annual dividend yield
3.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
April 11, 2013
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
3.00%
Operating margin
12.47%
Operational effectiveness
Return on assets
-2.05%
Return on equity
-4.10%
Income statement
Revenue (ttm)
12.37
Revenue per share (ttm)
12.37
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
130.84M
EBITDA
23.24M
Net income to common (ttm)
-652,000.00
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
-34.90%
Balance sheet
Total cash (mrq)
62.96M
Total cash per share (mrq)
5.19
Total debt (mrq)
112.45M
Total Debt/Equity (mrq)
669.89
Current ratio (mrq)
410.30%
Book value per share (mrq)
1.38
Cash flow
Cash flow statement
10.30M
Levered free cash flow (LFCF)
13.88M